1. Home
  2. |Insights
  3. |The CY2019 Proposed Rule for Medicare Advantage and Medicare Prescription Drug Benefit Programs

The CY2019 Proposed Rule for Medicare Advantage and Medicare Prescription Drug Benefit Programs

Webinar | 12.12.17, 8:00 AM EST - 9:30 AM EST

Register

CMS issued the long-awaited proposed rule that would make major changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs. CMS proposes many changes that are intended to increase transparency and alleviate administrative burdens on MA organizations and Part D sponsors. Other changes implement the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act. CMS also solicits comments on a number of important topics.


Please join us for a webinar during which members of our Health Care Group discuss some of the key provisions of the proposed rule.


Provisions that we will address include:

  • Implementation of the Comprehensive Addiction and Recovery Act of 2016
  • New Benefit Flexibility under Medicare Advantage
  • Tiering and Other Part D Changes
  • Changes to the Star Ratings Program and the Impact for Contract Consolidation
  • Changes to the Part C and Part D Medical Loss Ratio Requirements

Contact

Participants

Insights

Webinar | 10.16.25

The Artificial Intelligence Agenda from Capitol Hill to State Capitals: Where We Are and Where We Are (Probably) Going

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:...

View All Insights